PARIS (Reuters) - French President Macron said on Tuesday he did not want to waste time over negotiations concerning Britain's departure from the European Union and that it was in the EU's interest that Michel Barnier was the bloc's only negotiator.


10


Reuters

Latest News

CNN: 'Black Panther' crushes box office records in opening weekend

CNN: Fox News launching streaming service for 'superfans'

CNN: Why Thomas Friedman issued a 'code red' warning to America

CBS: Storm system triggers flooding, hundreds of crashes in Midwest

USA Today: Kerber easily advances to 2nd round in Dubai; Bellis wins

USA Today: 'Loud-mouth parents' blamed as HS deals with coach dismissals

USA Today: Missouri guard Terrence Phillips removed from team amid Title IX investigation

Los Angeles Times: Royalty unites! Queen Elizabeth II and Anna Wintour together at London Fashion Week

Los Angeles Times: Royalty unites! Queen Elizabeth II and Anna Wintour together at London Fashion Week

USA Today: Sea levels to rise 3 feet worldwide by 2300 — and it's likely to get worse

USA Today: Kerber easily advances to 2nd round in Dubai; Bellis wins

USA Today: Missouri guard Terrence Phillips removed from team amid Title IX investigation

USA Today: 'Loud-mouth parents' blamed as HS deals with coach dismissals

USA Today: Kerber easily advances to 2nd round in Dubai; Bellis wins

USA Today: Missouri guard Terrence Phillips removed from team amid Title IX investigation

USA Today: 'Loud-mouth parents' blamed as HS deals with coach dismissals

CNBC: Fees could sink your retirement savings. What to do about it

CNBC: Fees could sink your retirement savings. What to do about it

CTV News: Junos not naming replacement nominees after Hedley withdraws from 3 categories

CTV News: Junos not naming replacement nominees after Hedley withdraws from 3 categories

CBC: Mother outraged after school sends 'triggering' residential school book home to 3rd graders

BBC: Idrissa Gueye: Everton midfielder signs long-term deal until 2022

Reuters: BRIEF-Heat Biologics Gets Recommendation To Continue Patient Enrollment Of Ongoing Phase 2 Clinical Trial